MEI Pharma Inc. Stock
Pros and Cons of MEI Pharma Inc. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MEI Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MEI Pharma Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | 8.590% | 26.964% | 32.366% | 34.396% | 35.546% | 146.456% | 23.939% |
| Evolus Inc | - | -15.439% | -18.992% | -49.792% | -11.560% | -36.993% | 32.856% |
| Champions Oncology Inc | - | 0.901% | 10.891% | 17.647% | -3.448% | 43.590% | -36.364% |
Comments
MEI Pharma (NASDAQ:MEIP) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat